SUBSEQUENT EVENTS - Additional Information (Details)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 Months Ended |
12 Months Ended |
|
|
|
|
|
|
|
|
|
Mar. 19, 2026
EUR (€)
|
Mar. 12, 2026
USD ($)
|
Mar. 12, 2026
EUR (€)
|
Feb. 26, 2026
USD ($)
|
Feb. 17, 2026
USD ($)
$ / shares
shares
|
Feb. 13, 2026
$ / shares
shares
|
Feb. 12, 2026
USD ($)
$ / shares
shares
|
Feb. 09, 2026
shares
|
Feb. 06, 2026
USD ($)
$ / shares
shares
|
Jan. 15, 2026
USD ($)
$ / shares
|
Jan. 13, 2026
USD ($)
$ / shares
shares
|
Nov. 30, 2025
USD ($)
$ / shares
shares
|
Oct. 31, 2025
USD ($)
|
Sep. 16, 2025
USD ($)
|
Mar. 31, 2026
USD ($)
$ / shares
shares
|
Dec. 31, 2025
USD ($)
$ / shares
shares
|
Dec. 31, 2024
USD ($)
shares
|
May 12, 2026
USD ($)
|
Jan. 31, 2026 |
Jan. 13, 2026
EUR (€)
|
Nov. 30, 2025
EUR (€)
|
Jul. 22, 2025
shares
|
Apr. 29, 2025
USD ($)
|
Mar. 31, 2025
USD ($)
|
Dec. 31, 2023
USD ($)
|
[1] |
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common Stock, Shares, Issued | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
154,588,426
|
92,816,561
|
4,062,974
|
|
|
|
|
|
|
|
|
| Proceeds from the issuance of warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2,180,522
|
|
|
|
|
|
|
|
|
| Common stock, shares outstanding | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
154,588,426
|
92,816,561
|
4,062,974
|
|
|
|
|
|
|
|
|
| Common stock, shares authorized | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
900,000,000
|
900,000,000
|
900,000,000
|
|
|
|
|
900,000,000
|
|
|
|
| Preferred stock, shares authorized | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
50,000,000
|
50,000,000
|
|
|
|
|
|
50,000,000
|
|
|
|
| Nominal value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 749,905
|
|
|
|
|
|
|
|
|
|
|
| Stockholders' equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2,172,572
|
$ (15,182,173)
|
$ (37,836,506)
|
|
|
|
|
|
|
$ (38,977,924)
|
$ (32,545,921)
|
| Lyocon Acquisition [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Business acquisition date of acquisition agreement |
|
|
|
|
|
|
|
|
|
Jan. 15, 2026
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Paid in consideration to the sellers |
|
|
|
|
|
|
|
|
|
$ 750,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Payments to acquire ownership interest in cash |
|
|
|
|
|
|
|
|
|
750,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Aggregate purchase price |
|
|
|
|
|
|
|
|
|
2,310,558
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt instrument face amount |
|
|
|
|
|
|
|
|
|
1,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Promissory notes, principal amount |
|
|
|
|
|
|
|
|
|
$ 1,250,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Potential earn out payment period |
|
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Funding written notice period |
|
|
|
|
|
|
|
|
|
30 days
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of earn-out entitled |
|
|
|
|
|
|
|
|
|
30.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity Awards Equal to 0.07% of Market Cap [Member] | Lyocon Acquisition [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share price | $ / shares |
|
|
|
|
|
|
|
|
|
$ 3.49
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of consecutive trading days |
|
|
|
|
|
|
|
|
|
20 days
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of entitlement of equity awards to market cap |
|
|
|
|
|
|
|
|
|
0.07%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity Awards Equal to 0.10% of Market Cap [Member] | Lyocon Acquisition [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share price | $ / shares |
|
|
|
|
|
|
|
|
|
$ 4.99
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of consecutive trading days |
|
|
|
|
|
|
|
|
|
20 days
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of entitlement of equity awards to market cap |
|
|
|
|
|
|
|
|
|
0.10%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity Awards Equal to 0.15% of Market Cap [Member] | Lyocon Acquisition [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share price | $ / shares |
|
|
|
|
|
|
|
|
|
$ 9.98
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of consecutive trading days |
|
|
|
|
|
|
|
|
|
20 days
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of entitlement of equity awards to market cap |
|
|
|
|
|
|
|
|
|
0.15%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt [Member] | Lyocon Acquisition [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt instrument face amount |
|
|
|
|
|
|
|
|
|
$ 500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Short-Term Debt [Member] | Lyocon Acquisition [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt instrument face amount |
|
|
|
|
|
|
|
|
|
250,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Long-Term Debt [Member] | Lyocon Acquisition [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt instrument face amount |
|
|
|
|
|
|
|
|
|
250,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Cash Earnout [Member] | Lyocon Acquisition [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Contingent liabilities |
|
|
|
|
|
|
|
|
|
$ 1,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| NewCo [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of capital owned |
|
|
|
60.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maddox Joint Venture [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Development funds |
|
|
|
$ 4,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of development funds |
|
|
|
10.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of capital owned |
|
|
|
40.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Joint venture term |
|
|
|
1 year
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Joint venture, exclusive rights period |
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Notice of non-renewal |
|
|
|
90 days
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Orbit [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase of ownership interest |
|
|
|
|
|
|
|
|
|
22.00%
|
|
|
10.70%
|
|
10.70%
|
|
|
|
22.00%
|
|
|
|
|
|
|
| Paid in consideration to the sellers |
|
|
|
|
|
|
|
|
|
$ 2,000,000
|
|
|
|
|
|
$ 1,500,000
|
|
|
|
|
|
|
|
|
|
| Aggregate purchase price |
|
|
|
|
|
|
|
|
|
$ 16,592,107
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Non-cash consideration |
|
|
|
|
|
|
|
|
|
|
|
|
$ 900,000
|
|
|
|
|
|
|
|
|
|
|
|
|
| Tekne [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase of ownership interest |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2.90%
|
|
|
|
|
|
|
| Tekne [Member] | March 2026 Tekne Letter [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase of ownership interest |
70.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Payments to acquire ownership interest in cash | € |
€ 6,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Lyocon [Member] | Lyocon Acquisition [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase of ownership interest |
|
|
|
|
|
|
|
|
|
50.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| January 2026 Tekne Agreements [Member] | Tekne Transaction [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Business acquisition date of acquisition agreement |
|
|
|
|
|
|
|
|
|
|
|
Nov. 30, 2025
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity interest |
|
|
|
|
|
|
|
|
|
|
2.90%
|
2.90%
|
|
|
|
|
|
|
|
2.90%
|
2.90%
|
|
|
|
|
| Provision for convertible receivable | € |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
€ 13,000,000
|
€ 13,000,000
|
|
|
|
|
| Network Contract [Member] | Tekne Transaction [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Network contract initial term period |
|
|
|
|
|
|
|
|
|
|
|
Dec. 31, 2030
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Consultancy Services Exchange Actual Amount |
|
|
|
|
|
|
|
|
|
|
|
8.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Interest Acquisition [Member] | Tekne Transaction [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt instrument, maturity date |
|
|
|
|
|
|
|
|
|
|
|
Jan. 31, 2027
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument, Convertible, Conversion Price | $ / shares |
|
|
|
|
|
|
|
|
|
|
$ 1.25
|
$ 1.25
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity interest |
|
|
|
|
|
|
|
|
|
|
|
0.00%
|
|
|
|
|
|
|
|
|
0.00%
|
|
|
|
|
| Subordinated convertible note principal amount |
|
|
|
|
|
|
|
|
|
|
$ 1,740,000
|
$ 1,740,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subordinated Convertible Note Converted Shares | shares |
|
|
|
|
|
|
|
|
|
|
1,394,790
|
1,394,790
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Interest Acquisition [Member] | Tekne [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase of ownership interest |
|
|
|
|
|
|
|
|
|
|
|
2.90%
|
|
|
|
|
|
|
|
|
2.90%
|
|
|
|
|
| Interest Acquisition [Member] | Tekne [Member] | Tekne Purchase Agreement [member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase of ownership interest |
|
|
|
|
|
|
|
|
|
|
2.90%
|
2.90%
|
|
|
|
|
|
|
|
2.90%
|
2.90%
|
|
|
|
|
| GP Authorization [Member] | March 2026 Tekne Letter [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Capital increase amount | € |
€ 13,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| GP Authorization [Member] | Tekne [Member] | March 2026 Tekne Letter [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of capital increase |
25.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of subject to obtaining interest |
60.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of additional subject to obtaining interest |
10.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| GP Authorization [Member] | Mr. D'Arrezzo [Member] | March 2026 Tekne Letter [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of subject to obtaining interest |
2.90%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| H&K Investment Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common Stock, Shares, Issued | shares |
|
|
|
|
|
|
|
|
295,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of outstanding common shares |
|
|
|
|
|
|
|
|
0.80%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Aggregate purchase price |
|
|
|
|
|
|
|
|
$ 15,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Placement Agency Agreement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of cash fees on equity offering |
|
|
|
|
|
|
7.50%
|
|
|
|
|
|
|
7.50%
|
|
|
|
|
|
|
|
|
|
|
|
| Gross proceeds from equity public offering |
|
|
|
|
|
|
$ 10,000,000
|
|
|
|
|
|
|
$ 10,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Additional percentage of cash fees on equity offering |
|
|
|
|
|
|
6.00%
|
|
|
|
|
|
|
6.00%
|
|
|
|
|
|
|
|
|
|
|
|
| Maximum amount reimbursement for reasonable accountable and out of pocket expenses |
|
|
|
|
|
|
$ 60,000
|
|
|
|
|
|
|
$ 100,000
|
|
|
|
|
|
|
|
|
|
|
|
| Bond Subscription Agreement [Member] | SYME 3 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Nominal value | € |
|
|
€ 5,250,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subscription price | € |
|
|
4,824,294
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subscription price paid |
|
$ 5,668,545
|
4,824,294
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issuance in variable rate bonds | € |
|
|
€ 30,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity date |
|
2029-03
|
2029-03
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Basis spread margin on variable rate |
|
7.50%
|
7.50%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Cap rate |
12.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument, Variable Interest Rate, Type [Extensible Enumeration] |
|
us-gaap:EurodollarMember
|
us-gaap:EurodollarMember
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Notice for redemption on bond payment date |
|
120 days
|
120 days
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Tekne Convertible Receivable [Member] | Tekne Transaction [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt instrument, maturity date |
|
|
|
|
|
|
|
|
|
|
|
Jan. 13, 2027
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Provision for convertible receivable | € |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
€ 13,000,000
|
|
|
|
|
| Convertible receivable annual interest rate |
|
|
|
|
|
|
|
|
|
|
|
4.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Newly issued shares percentage of capital increase |
|
|
|
|
|
|
|
|
|
|
|
25.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Tekne Convertible Receivable [Member] | Tekne [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase of ownership interest |
|
|
|
|
|
|
|
|
|
|
|
27.90%
|
|
|
|
|
|
|
|
|
27.90%
|
|
|
|
|
| Tekne Convertible Receivable [Member] | Tekne [Member] | March 2026 Tekne Letter [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Convertible receivable interest rate |
32.10%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Indigo Pre-Funded Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common Stock, Shares, Issued | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11,170,330
|
|
|
|
|
|
|
|
|
|
|
| Number of warrants to purchase the shares issued (in shares) | shares |
|
|
|
|
|
|
|
|
11,176,650
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| February 2026 Offering [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of offering common warrant exercisable |
|
|
|
|
150.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from the issuance of warrants |
|
|
|
|
$ 10,897,789
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Minimum percentage holding of securities acquired |
|
|
|
|
|
|
75.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Gross proceeds from equity public offering |
|
|
|
|
$ 11,994,929
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares issued | shares |
|
|
|
|
11,699,226
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| February 2026 Offering Common Warrant Shares [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of warrants to purchase the shares issued (in shares) | shares |
|
|
|
|
32,792,859
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Price per share | $ / shares |
|
|
|
|
$ 0.5489
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of sales on common stock |
|
|
|
|
|
|
4.99%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| February 2026 Pre-Funded Warrant Shares [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of warrants to purchase the shares issued (in shares) | shares |
|
|
|
|
10,162,680
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Price per share | $ / shares |
|
|
|
|
$ 0.5484
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of sales on common stock |
|
|
|
|
|
|
9.99%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| February 2026 Offering Pre Funded Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common Stock, Shares, Issued | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8,036,072
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from the issuance of warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 4,038
|
|
|
|
|
|
|
|
|
|
|
| February 2026 Offering Placement Agent Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of warrants to purchase the shares issued (in shares) | shares |
|
|
|
|
437,239
|
|
437,239
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants and rights outstanding term |
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant exercise price | $ / shares |
|
|
|
|
$ 0.6861
|
|
|
|
|
|
|
|
|
|
$ 0.6861
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from the issuance of warrants |
|
|
|
|
$ 185,018
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share price | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.48
|
|
|
|
|
|
|
|
|
|
|
| Series A Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, shares authorized | shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
50,000,000
|
50,000,000
|
|
|
|
|
|
|
|
|
|
| Series A Preferred Stock [Member] | Indigo Pre-Funded Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock conversion shares | shares |
|
|
|
|
|
|
|
|
844,938
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maximum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant exercise price | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 15.87
|
|
|
|
|
|
|
|
|
|
| Maximum [Member] | Tekne Convertible Receivable [Member] | March 2026 Tekne Letter [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Increase of convertible receivable amount | € |
€ 16,692,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Minimum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant exercise price | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 10.88
|
|
|
|
|
|
|
|
|
|
| Stockholders' equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2,000,000
|
|
|
| Minimum [Member] | Tekne Convertible Receivable [Member] | March 2026 Tekne Letter [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Increase of convertible receivable amount | € |
€ 13,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Price per share | $ / shares |
|
|
|
|
|
$ 4.99
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Minimum trading price | $ / shares |
|
|
|
|
|
$ 0.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock, shares outstanding | shares |
|
|
|
|
|
122,060,332
|
609,081,058
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock, shares authorized | shares |
|
|
|
|
|
900,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, shares authorized | shares |
|
|
|
|
|
50,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Member] | Lyocon Acquisition [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Business acquisition date of acquisition agreement |
|
|
|
|
|
|
|
|
|
Jan. 15, 2026
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Paid in consideration to the sellers |
|
|
|
|
|
|
|
|
|
$ 2,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Payments to acquire ownership interest in cash |
|
|
|
|
|
|
|
|
|
750,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt instrument face amount |
|
|
|
|
|
|
|
|
|
$ 1,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt instrument, maturity date |
|
|
|
|
|
|
|
|
|
Jul. 15, 2026
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Promissory notes, principal amount |
|
|
|
|
|
|
|
|
|
$ 625,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Conversion price equal to discount on lowest volume-weighted average price |
|
|
|
|
|
|
|
|
|
30.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Potential earn out payment period |
|
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Funding written notice period |
|
|
|
|
|
|
|
|
|
30 days
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of earn-out entitled |
|
|
|
|
|
|
|
|
|
30.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Volume-weighted average price of conversion period |
|
|
|
|
|
|
|
|
|
60 days
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument, Convertible, Conversion Price | $ / shares |
|
|
|
|
|
|
|
|
|
$ 1.47
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Borad of director initial term of designation |
|
|
|
|
|
|
|
|
|
3 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Borad of director renewal period of designation |
|
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Member] | Orbit Acquisition and Amendment [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Business combination effective date of acquisition |
|
|
|
|
|
|
|
|
|
Jan. 15, 2026
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Business acquisition date of acquisition agreement |
|
|
|
|
|
|
|
Feb. 09, 2026
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Non-cash consideration |
|
|
|
|
|
|
|
|
|
$ 8,750,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock issued in lieu of oligation | shares |
|
|
|
|
|
|
|
10,020,040
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Member] | Equity Awards Equal to 0.07% of Market Cap [Member] | Lyocon Acquisition [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share price | $ / shares |
|
|
|
|
|
|
|
|
|
$ 3.49
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of consecutive trading days |
|
|
|
|
|
|
|
|
|
20 days
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of entitlement of equity awards to market cap |
|
|
|
|
|
|
|
|
|
0.07%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Member] | Equity Awards Equal to 0.10% of Market Cap [Member] | Lyocon Acquisition [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share price | $ / shares |
|
|
|
|
|
|
|
|
|
$ 4.99
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of consecutive trading days |
|
|
|
|
|
|
|
|
|
20 days
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of entitlement of equity awards to market cap |
|
|
|
|
|
|
|
|
|
0.10%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Member] | Equity Awards Equal to 0.15% of Market Cap [Member] | Lyocon Acquisition [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share price | $ / shares |
|
|
|
|
|
|
|
|
|
$ 9.98
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of consecutive trading days |
|
|
|
|
|
|
|
|
|
20 days
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of entitlement of equity awards to market cap |
|
|
|
|
|
|
|
|
|
0.15%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Member] | Debt [Member] | Lyocon Acquisition [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt instrument face amount |
|
|
|
|
|
|
|
|
|
$ 500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Member] | Short-Term Debt [Member] | Lyocon Acquisition [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt instrument face amount |
|
|
|
|
|
|
|
|
|
250,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Member] | Long-Term Debt [Member] | Lyocon Acquisition [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt instrument face amount |
|
|
|
|
|
|
|
|
|
250,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Member] | Cash Earnout [Member] | Lyocon Acquisition [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Contingent liabilities |
|
|
|
|
|
|
|
|
|
$ 1,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Member] | NewCo [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of capital owned |
|
|
|
60.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Member] | Maddox Joint Venture [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Development funds |
|
|
|
$ 4,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of development funds |
|
|
|
10.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of capital owned |
|
|
|
40.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Joint venture term |
|
|
|
1 year
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Joint venture, exclusive rights period |
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Notice of non-renewal |
|
|
|
90 days
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Member] | Orbit [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase of ownership interest |
|
|
|
|
|
|
|
|
|
22.00%
|
|
|
|
|
|
|
|
|
22.00%
|
|
|
|
|
|
|
| Subsequent Event [Member] | Tekne [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase of ownership interest |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2.90%
|
|
|
|
|
|
|
| Subsequent Event [Member] | Tekne [Member] | March 2026 Tekne Letter [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase of ownership interest |
70.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Payments to acquire ownership interest in cash | € |
€ 6,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Member] | Lyocon [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase of ownership interest |
|
|
|
|
|
|
|
|
|
50.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Member] | January 2026 Tekne Agreements [Member] | Tekne Transaction [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Business combination effective date of acquisition |
|
|
|
|
|
|
|
|
|
|
Jan. 13, 2026
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity interest |
|
|
|
|
|
|
|
|
|
|
2.90%
|
|
|
|
|
|
|
|
|
2.90%
|
|
|
|
|
|
| Subsequent Event [Member] | GP Authorization [Member] | March 2026 Tekne Letter [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Capital increase amount | € |
€ 13,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Member] | GP Authorization [Member] | Tekne [Member] | March 2026 Tekne Letter [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of capital increase |
25.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of subject to obtaining interest |
60.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of additional subject to obtaining interest |
10.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Member] | GP Authorization [Member] | Mr. D'Arrezzo [Member] | March 2026 Tekne Letter [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of subject to obtaining interest |
2.90%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Member] | H&K Investment Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common Stock, Shares, Issued | shares |
|
|
|
|
|
|
|
|
295,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of outstanding common shares |
|
|
|
|
|
|
|
|
0.80%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Aggregate purchase price |
|
|
|
|
|
|
|
|
$ 15,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument, Convertible, Conversion Price | $ / shares |
|
|
|
|
|
|
|
|
$ 0.756
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subordinated convertible note maturity date |
|
|
|
|
|
|
|
|
Mar. 19, 2027
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Member] | H&K Investment Agreement [Member] | Heckler & Koch AG Investment [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity interest |
|
|
|
|
|
|
|
|
0.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Member] | Placement Agency Agreement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of cash fees on equity offering |
|
|
|
|
|
|
7.50%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Gross proceeds from equity public offering |
|
|
|
|
|
|
$ 10,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Additional percentage of cash fees on equity offering |
|
|
|
|
|
|
6.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maximum amount reimbursement for reasonable accountable and out of pocket expenses |
|
|
|
|
|
|
$ 60,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Member] | Bond Subscription Agreement [Member] | SYME 3 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Nominal value | € |
|
|
€ 5,250,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subscription price | € |
|
|
5,250,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subscription price paid | € |
|
|
4,824,294
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issuance in variable rate bonds | € |
|
|
€ 30,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity date |
|
2029-03
|
2029-03
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Basis spread margin on variable rate |
|
7.50%
|
7.50%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Cap rate |
|
12.00%
|
12.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument, Variable Interest Rate, Type [Extensible Enumeration] |
|
us-gaap:EurodollarMember
|
us-gaap:EurodollarMember
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Notice for redemption on bond payment date |
|
120 days
|
120 days
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Member] | Tekne Convertible Receivable [Member] | Tekne [Member] | March 2026 Tekne Letter [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Convertible receivable interest rate |
32.10%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Member] | Indigo Pre-Funded Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of warrants to purchase the shares issued (in shares) | shares |
|
|
|
|
|
|
|
|
11,176,650
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant exercise price | $ / shares |
|
|
|
|
|
|
|
|
$ 0.0005
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Member] | February 2026 Offering [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of offering common warrant exercisable |
|
|
|
|
150.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from the issuance of warrants |
|
|
|
|
$ 11,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Minimum percentage holding of securities acquired |
|
|
|
|
|
|
75.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares issued | shares |
|
|
|
|
11,699,227
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Member] | February 2026 Offering Common Warrant Shares [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of warrants to purchase the shares issued (in shares) | shares |
|
|
|
|
32,792,859
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants and rights outstanding term |
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Price per share | $ / shares |
|
|
|
|
$ 0.5489
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of sales on common stock |
|
|
|
|
|
|
4.99%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Member] | February 2026 Pre-Funded Warrant Shares [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of warrants to purchase the shares issued (in shares) | shares |
|
|
|
|
10,162,680
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Price per share | $ / shares |
|
|
|
|
$ 0.5484
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant exercise price | $ / shares |
|
|
|
|
0.0005
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of sales on common stock |
|
|
|
|
|
|
9.99%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Member] | February 2026 Offering Common Warrant Shares until Six Month [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant exercise price | $ / shares |
|
|
|
|
0.6587
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Member] | February 2026 Offering Common Warrant Shares After Six Month [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant exercise price | $ / shares |
|
|
|
|
$ 0.5489
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Member] | February 2026 Offering Placement Agent Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of warrants to purchase the shares issued (in shares) | shares |
|
|
|
|
|
|
437,239
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants and rights outstanding term |
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant exercise price | $ / shares |
|
|
|
|
|
|
$ 0.6861
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of common stock and common stock warrant offering price per share |
|
|
|
|
|
|
125.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Member] | Series A Preferred Stock [Member] | Indigo Pre-Funded Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock conversion shares | shares |
|
|
|
|
|
|
|
|
844,938
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Member] | Maximum [Member] | Tekne Convertible Receivable [Member] | March 2026 Tekne Letter [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Increase of convertible receivable amount | € |
€ 16,692,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Member] | Maximum [Member] | February 2026 Offering Common Warrant Shares [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common Warrants exercisable | shares |
|
|
|
|
18,218,255
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Member] | Minimum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders' equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 4,000,000
|
|
|
|
|
|
|
|
| Subsequent Event [Member] | Minimum [Member] | H&K Investment Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of affiliates beneficially owning, outstanding shares of common stock |
|
|
|
|
|
|
|
|
9.90%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Member] | Minimum [Member] | Tekne Convertible Receivable [Member] | March 2026 Tekne Letter [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Increase of convertible receivable amount | € |
€ 13,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Member] | Minimum [Member] | Indigo Pre-Funded Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of affiliates beneficially owning, outstanding shares of common stock |
|
|
|
|
|
|
|
|
4.99%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|